Altice USA Inc (ATUS) concluded trading on Wednesday at a closing price of $2.65, with 4.39 million shares of worth about $11.64 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 0.38% during that period and on May 07, 2025 the price saw no change. Currently the company’s common shares owned by public are about 278.98M shares, out of which, 232.17M shares are available for trading.
Stock saw a price change of 6.85% in past 5 days and over the past one month there was a price change of 14.72%. Year-to-date (YTD), ATUS shares are showing a performance of 9.96% which increased to 33.84% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.52 but also hit the highest price of $3.20 during that period. The average intraday trading volume for Altice USA Inc shares is 3.24 million. The stock is currently trading 10.46% above its 20-day simple moving average (SMA20), while that difference is up 5.21% for SMA50 and it goes to 10.12% higher than SMA200.
Altice USA Inc (NYSE: ATUS) currently have 278.98M outstanding shares and institutions hold larger chunk of about 52.46% of that.
The stock has a current market capitalization of $1.24B and its 3Y-monthly beta is at 1.66. It has posted earnings per share of -$0.22 in the same period. It has Quick Ratio of 0.32. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ATUS, volatility over the week remained 6.27% while standing at 8.05% over the month.
Stock’s fiscal year EPS is expected to rise by 8.66% while it is estimated to increase by 28.09% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Raymond James on February 18, 2025 offering an Outperform rating for the stock and assigned a target price of $3.50 to it. Coverage by UBS stated Altice USA Inc (ATUS) stock as a Neutral in their note to investors on August 02, 2024, suggesting a price target of $2 for the stock. On July 01, 2024, Goldman Initiated their recommendations, while on April 24, 2024, BofA Securities Resumed their ratings for the stock with a price target of $1.50. Stock get an Underweight rating from JP Morgan on April 11, 2024.
